Product Information

OXYBUTYNIN CL ER 15 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1327 per EA under NDC 72888003205. Its NADAC has been published 106 times since Nov 13, 2024.

FDA first approved this application on Oct 27, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXYBUTYNIN CL ER 15 MG TABLET

Oxybutynin Chloride
$0.1327per EA

Strength

15 mg/1

NDC

72888003205

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXYBUTYNIN CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214415

FDA Approved

10/27/2020

TE Code

AB

On Market Since

10/27/2020

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for OXYBUTYNIN CL ER 15 MG TABLET has been published 106 times since Nov 13, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.1327 per EA
All-time high$0.1468 (May 14, 2025)
All-time low$0.1161 (Dec 17, 2025)
52-week high$0.1327
52-week low$0.1161
Median price$0.1253
Average price$0.1267
Largest weekly change-11.3% (Nov 20, 2024)
Weeks tracked106
Tracking sinceNov 13, 2024

Price History

1W

+3.1%

1M

+6.1%

3M

+5.9%

6M

+14.2%

1Y

+11.1%

3Y

N/A

5Y

N/A

All

-1.1%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXYBUTYNIN CL ER 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 15 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1327 per EA (NDC 72888003205), effective Nov 18, 2026.

How has the price of OXYBUTYNIN CL ER 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has held within roughly two percent of its current level. It has been tracked across 106 weekly CMS publications since Nov 13, 2024.

What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 15 MG TABLET?

Since Nov 13, 2024, the NADAC for OXYBUTYNIN CL ER 15 MG TABLET has ranged from a low of $0.1161 (Dec 17, 2025) to a high of $0.1468 (May 14, 2025), with a median of $0.1253 per EA.

Are there cheaper alternatives to OXYBUTYNIN CL ER 15 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYBUTYNIN CL ER 15 MG TABLET, is $0.1161 per EA — about 13% below OXYBUTYNIN CL ER 15 MG TABLET.

Who manufactures OXYBUTYNIN CL ER 15 MG TABLET?

OXYBUTYNIN CL ER 15 MG TABLET (NDC 72888003205) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.